Advanced Emissions Solutions to Attend the Annual Roth Investor Conference on March 13

CEO Greg Marken to meet with institutional investors

GREENWOOD VILLAGE, Colo., March 09, 2023 (GLOBE NEWSWIRE) — Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”), a leader in environmental solutions for power generation, industrial and municipal water purification markets, today announced that it will attend the 35th Annual ROTH Conference being held in Laguna Niguel, California on March 13-14, 2023.

The Company’s Chief Executive Officer, Greg Marken, will attend the conference on Monday, March 13, and will be participating in one-on-one meetings with analysts and investors.

The conference will feature individual and small group meetings, industry panels, presentations and fireside chats with institutional investors, analysts, family offices and high net-worth investors.

Investors that wish to meet with Mr. Marken are welcome to contact their Roth representative. Alternatively, they may contact ADES’s investor relations team to coordinate meetings either face-to-face during the conference or via an online virtual meeting in the weeks following.

About Advanced Emissions Solutions, Inc.

Advanced Emissions Solutions, Inc. serves as the holding entity for a family of companies that provide environmental solutions to customers in the power generation, industrial and municipal water purification markets.

ADA brings together ADA Carbon Solutions, LLC, a leading provider of powder activated carbon (“PAC”) and ADA-ES, Inc., the providers of ADA® M-Prove™ Technology. We provide products and services to control mercury and other contaminants at coal-fired power generators and other industrial companies. Our broad suite of complementary products control contaminants and help our customers meet their compliance objectives consistently and reliably.

CarbPure Technologies LLC, (“CarbPure”), formed in 2015 provides high-quality PAC and granular activated carbon ideally suited for treatment of potable water and wastewater. Our affiliate company, ADA Carbon Solutions, LLC manufactures the products for CarbPure.

FluxSorb, LLC, formed in 2022, is an emerging technology company that introduces highly engineered activated carbon products with a focus on the emerging remediation markets. Our vision is to partner with our customers to collaborate, develop and deploy best in class activated carbon solutions to meet even the most extreme challenges.

Arq is an environmental technology business founded in 2015 that has developed a novel process for producing specialty carbon products from coal mining waste. Arq has the technology and large-scale manufacturing facilities to produce a micro-fine hydrocarbon powder, Arq powder™, that can be used as a feedstock to produce activated carbon and as an additive for other products.

Caution on Forward-Looking Statements

Statements in this press release regarding the Company’s business that are not historical facts, including statements concerning optimizing cash flows and maximizing shareholder value, are forward-looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report on Form 10-K.

Source: Advanced Emissions Solutions, Inc.

Investor Contact:

Alpha IR Group
Ryan Coleman or Chris Hodges
312-445-2870
[email protected]



Enovix Announces Design Approval of Its Next-Generation Autoline

FREMONT, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced that its Board of Directors approved the design of its next-generation manufacturing line (“Gen2 Autoline”), a key milestone in its journey to scale. The Gen2 Autoline is anticipated to increase battery manufacturing throughput by over 10x compared to the current throughput of the Gen1 line. The principal enhancements in the Gen2 Autoline involve increased levels of automation, parallelism, and in-line metrology.

T.J. Rodgers, Enovix Executive Chairman, said, “I am pleased to report that a subcommittee of our board, which includes me and Greg Reichow, who built and ran Tesla’s auto assembly plant in Fremont, California, approved the purchase for the Gen2 Autoline design ahead of our target date of March 15. The approval of the Gen2 equipment purchase was contingent on the successful completion of proof of concept (“POC”) hardware modules that demonstrated basic functionality at each step in our process prior to Gen2 Autoline construction. This approval paves the way for our Gen2 Autoline equipment vendors to finalize builds in order to hit our next major milestone of factory acceptance testing (“FAT”), during which a team of our engineers will verify full autoline functionality at the vendor’s factory prior to the delivery of the equipment to Enovix. As I mentioned in previous communications, we intend to share our progress as milestones are achieved.”

Rodgers continued, “Just as important, the manufacturing engineering team under our new COO, Ajay Marathe, has completed the arduous requirements of our Equipment Procurement Review – Process Change Review (EPR-PCR) process, a spec system which was perfected at Cypress Semiconductor on four generations of silicon wafer fabs in the U.S, nine assembly and test autolines in the Philippines, and 16 autolines at SunPower’s Philippines and Malaysia plants that produce SunPower’s world-class IBC solar cell. These EPR-PCR specs require man-years of work to be done properly and were not fully completed in our Fab-1 Gen1 line, partly due to Covid-mandated travel restrictions.”

Dr. Raj Talluri, President and CEO of Enovix, said, “Receiving Gen2 Autoline design approval is a testament to the hard work of the team and a major step forward in our journey to scale our production capabilities. In addition, our continuous Gen1 progress strengthens our confidence in scaling up our Gen2 Autoline, since many of the process steps are the same. Enovix has developed a breakthrough battery that has significant performance advantages over the current Lithium-ion batteries in commercial devices today. I believe the company’s proprietary technology will transform the battery industry. The management team is laser-focused on scaling production to meet customer demand.”

Follow the company’s progress here: https://www.enovix.com/scale/

About Enovix

Enovix is on a mission to power the technologies of the future. Everything from IoT, mobile and computing devices, to the vehicle you drive, needs a better battery. The company’s disruptive architecture enables a battery with high energy density and capacity without compromising safety. Enovix is scaling its silicon-anode, lithium-ion battery manufacturing capabilities to meet customer demand. For more information visit www.enovix.com and follow us on LinkedIn.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, about us and our industry that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “believe”, “will”, “may”, “estimate”, “continue”, “anticipate”, “intend”, “should”, “plan”, “expect”, “predict”, “could”, “potentially”, “target”, “project”, “believe”, “continue” or the negative of these terms or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements regarding the anticipated increase of battery manufacturing throughput by the Gen2 line of over 10x compared to the current throughput of the Gen1 line, the increased levels of automation, parallelism, and in-line metrology in the Gen2 Autoline, paving the way for our Gen2 Autoline equipment vendors to finalize builds, hitting our next major milestone of factory acceptance testing (“FAT”) of the Gen2 Autoline, delivery of the equipment to Enovix, and our journey to scale our production capabilities. For additional information on these risks and uncertainties and other potential factors that could affect our business and financial results or cause actual results to differ from the results predicted, please refer to our filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our most recently filed annual periodic reports on Form 10-K and quarterly report on Form 10-Q and other documents that we have filed, or that we will file, with the SEC. Any forward-looking statements made by us in this press release speak only as of the date on which they are made and subsequent events may cause these expectations to change. We disclaim any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law.

For media inquiries, please contact:

Enovix Corporation
Kristin Atkins
Phone: +1 (650) 815-6934
Email: [email protected]

For investor inquiries, please contact:

Enovix Corporation
Charles Anderson
Phone: +1 (612) 229-9729
Email: [email protected]

The Blueshirt Group
Gary Dvorchak, CFA
Phone: (323) 240-5796
Email: [email protected]



Franklin Resources, Inc. Announces Month-End Assets Under Management

Franklin Resources, Inc. Announces Month-End Assets Under Management

SAN MATEO, Calif.–(BUSINESS WIRE)–
Franklin Resources, Inc. (Franklin Templeton) (NYSE: BEN) today reported preliminary month-end assets under management (AUM) of $1,416.5 billion at February 28, 2023, compared to $1,451.9 billion at January 31, 2023. This month’s decrease in AUM reflected the impact of negative markets, partially offset by long-term net inflows inclusive of the previously disclosed $7.5 billion institutional mandate invested across fixed income strategies.

By Asset Class:

(In USD billions)

Preliminary

28-Feb-23

31-Jan-23

31-Dec-22

30-Sep-22

28-Feb-22

Fixed Income

502.4

512.1

494.8

490.9

612.5

Equity

431.9

445.5

419.1

392.3

509.8

Alternative

256.3

257.9

257.4

225.1

155.0

Multi-Asset

144.2

147.2

141.4

131.5

148.6

Long Term:

1,334.8

1,362.7

1,312.7

1,239.8

1,425.9

Cash Management

81.7

89.2

75.0

57.6

61.0

Total

1,416.5

1,451.9

1,387.7

1,297.4

1,486.9

About Franklin Templeton

Franklin Resources, Inc. [NYSE:BEN] is a global investment management organization with subsidiaries operating as Franklin Templeton and serving clients in over 155 countries. Franklin Templeton’s mission is to help clients achieve better outcomes through investment management expertise, wealth management and technology solutions. Through its specialist investment managers, the company offers specialization on a global scale, bringing extensive capabilities in fixed income, equity, alternatives and multi-asset solutions. With offices in more than 30 countries and approximately 1,300 investment professionals, the California-based company has over 75 years of investment experience. The company posts information that may be significant for investors in the Investor Relations and News Center sections of its website, and encourages investors to consult those sections regularly. For more information, please visit investors.franklinresources.com.

Forward-Looking Statements

The financial results in this press release are preliminary. Some of the statements herein may include forward-looking statements that reflect our current views with respect to future events, financial performance and market conditions. Such statements are provided under the “safe harbor” protection of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and generally can be identified by words or phrases written in the future tense and/or preceded by words such as “anticipate, “believe,” “could,” “depends,” “estimate,” “expect,” “intend,” “likely,” “may,” “plan,” “potential,” “preliminary,” “seek,” “should,” “will,” “would,” or other similar words or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements.

Forward-looking statements involve a number of known and unknown risks, uncertainties and other important factors that may cause actual results and outcomes to differ materially from any future results or outcomes expressed or implied by such forward-looking statements, including pandemic-related risks, market and volatility risks, investment performance and reputational risks, global operational risks, competition and distribution risks, third-party risks, technology and security risks, human capital risks, cash management risks, and legal and regulatory risks. While forward-looking statements are our best prediction at the time that they are made, you should not rely on them and are cautioned against doing so. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other possible future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. They are neither statements of historical fact nor guarantees or assurances of future performance. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them.

These and other risks, uncertainties and other important factors are described in more detail in our recent filings with the U.S. Securities and Exchange Commission, including, without limitation, in Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022 and our subsequent Quarterly Reports on Form 10-Q. If a circumstance occurs after the date of this press release that causes any of our forward- looking statements to be inaccurate, whether as a result of new information, future developments or otherwise, we undertake no obligation to announce publicly the change to our expectations, or to make any revision to our forward-looking statements, to reflect any change in assumptions, beliefs or expectations, or any change in events, conditions or circumstances upon which any forward-looking statement is based, unless required by law.

Investor Relations: Selene Oh (650) 312-4091, [email protected]

Media Relations: Matt Walsh (650) 312-2245, [email protected]

investors.franklinresources.com

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Jason Hanson to Succeed Diane Offereins as Executive Vice President, President of Payment Services for Discover Financial Services

Jason Hanson to Succeed Diane Offereins as Executive Vice President, President of Payment Services for Discover Financial Services

 

RIVERWOODS, Ill.–(BUSINESS WIRE)–
Discover Financial Services (NYSE: DFS) today announced that Jason Hanson will succeed Diane Offereins as executive vice president, president of payment services. Hanson will oversee Discover’s Payment Services, which encompasses the Discover Global Network, PULSE, and Diner’s Club International. Offereins plans to retire after more than 25 years with the company effective June 30.

Offereins first served as Chief Information Officer at Discover before moving to Payment Services. She helped lead Discover’s transition to an independent, publicly traded company in 2007 and its acquisition of PULSE and Diners Club International. Offereins was named one of the Most Powerful Women in Finance by American Banker for the last 15 consecutive years.

Beyond her role at Discover, Offereins has long advocated for the advancement of women, both within Discover, and externally where she has served as a member and Chair of the Chicago Network, an organization committed to empowering women.

“Under Diane’s leadership of our Payments business, we successfully expanded into debit and established a global payments network,” said Roger Hochschild, CEO and president of Discover. “She has built a lasting legacy at Discover as well as a talented team of leaders throughout which is enabling a smooth succession. Like Diane, Jason has deep industry expertise and is well positioned to lead Discover’s Payments business.”

Hanson joined Discover in 2019 and currently serves as Senior Vice President, Network Operations and is a member of Discover’s Management Committee. He has led Discover’s payments strategy, business development, global acceptance, and network operations functions and overseen initiatives that contributed to Discover’s Payments growth.

Prior to Discover, Hanson led corporate development efforts at FIS/Worldpay and spent over a decade with McKinsey & Company as a partner in their Payments and Private Equity practices. He is a graduate of the United States Military Academy and a U.S. Army veteran.

Offereins and Hanson will work together until Offereins’s departure to ensure a seamless transition. Once promoted, Hanson will serve on the Executive Committee and report directly to Hochschild.

About Discover

Discover Financial Services (NYSE: DFS) is a digital banking and payment services company with one of the most recognized brands in U.S. financial services. Since its inception in 1986, the company has become one of the largest card issuers in the United States. The company issues the Discover® card, America’s cash rewards pioneer, and offers private student loans, personal loans, home loans, checking and savings accounts and certificates of deposit through its banking business. It operates the Discover Global Network® comprised of Discover Network, with millions of merchants and cash access locations; PULSE®, one of the nation’s leading ATM/debit networks; and Diners Club International®, a global payments network with acceptance around the world. For more information, visit www.discover.com/company.

Matthew Towson

Public Relations

224-405-5649

[email protected]

 

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Finance Banking Professional Services Technology Fintech

MEDIA:

Logo
Logo

Faraday Future Plans to Host a Special Meeting of Stockholders on March 30th, 2023, Announces Plans for Additional $50 Million Offering to Existing Shareholders

Faraday Future Plans to Host a Special Meeting of Stockholders on March 30th, 2023, Announces Plans for Additional $50 Million Offering to Existing Shareholders

  • Affirmative vote required on March 30, 2023 special meeting of stockholders in order for the Company to receive remaining funds as contemplated in the $135 million fundraising announced on February 5, 2023; initial funding amounts have been received by the Company as planned
  • Company has already received non-binding indications of interest for nearly full amount of additional $50 million fundraising to support scaling FF 91 Futurist production, and the Company is providing its stockholders the opportunity to invest

LOS ANGELES–(BUSINESS WIRE)–
Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced it will hold a special meeting of stockholders on Thursday, March 30th, 2023. The Company recommends that all FF stockholders as of February 3, 2023 submit proxies in favor of the proposals. The Company also announced plans for an additional $50 million raise from institutional investors and potential additional raise from its stockholders to further strengthen the Company’s balance sheet and fund the production ramp-up.

The special stockholder meeting on March 30th will be held to consider the following two topics:

  1. The Company needs approval from its stockholders for certain transactions involving the Tranche C and D notes and warrants issued or to be issued to FF Simplicity Ventures LLC, Senyun International Limited, Acuitas Capital, LLC, and/or their affiliates. This approval is required by the Nasdaq Stock Market rules and regulations for the Company to issue shares that exceed 19.99% of the total number of outstanding shares of Common Stock in relation to those notes and warrants.

  2. The Company is seeking stockholder ratification of the selection of Mazars as the independent registered public accounting firm of the Company for the year ended December 31, 2022.

The Company has received initial funding from investors as planned based on investment agreement. Stockholder approval of the first proposal above is a condition to complete the remaining portion of the recently announced financing commitments of $135.0 million in convertible secured notes. These funds will provide a pivotal path for providing support to the Company in achieving its upcoming Start of Production (“SOP”) and Start of Delivery (“SOD”) milestones as well as further long-term goals. Additional information about the special stockholders meeting can be found in our definitive proxy statement on Schedule 14A previously filed with the SEC.

FFIE stockholders may cast their vote over the Internet, by telephone or by completing and mailing the proxy card by following the instructions on the proxy card. Signing and returning the proxy card or submitting your proxy by Internet or telephone in advance of the special meeting will not prevent you from voting at the special meeting if you attend virtually but will assure that your vote is counted if you are unable to attend the special meeting.

Proxies forwarded by or for banks, brokers or other nominees should be returned as requested by them. We encourage you to vote promptly to ensure your vote is represented at the special meeting, regardless of whether you plan to attend the special meeting.

You can go to the proxy section of www.ff.com to access voting details at this address to participate in the meeting March 30th: www.ff.com/vote

As the new board of directors and management strive to maximize stakeholder interest, the Company would like to provide FFIE stockholders that are accredited investors an investment opportunity at this exciting turning point that will help the Company scale production of the FF 91 Futurist vehicles. FF expects that once the Company starts production and delivery of the FF 91 Futurist vehicles as anticipated, FF’s cost of capital will drop considerably as the Company continues to hit milestones and begins to generate revenue.

Please see attached letter for full details:

English:

https://www.ff.com/us/letter-to-investors-0308/

Chinese:

https://www.faradayfuturecn.com/cn/letter-to-investors-0308/

FFIE is immensely grateful to its stockholders for their unwavering trust and appreciate their continued support. Over the past few months, FF has taken steps to strengthen the board and management and is dedicated to ensuring the best interests of FF’s stakeholders. These efforts demonstrate a commitment to the promises as the Company establishes a strong foundation to achieve the ultimate goal of generating value for its stakeholders.

FF is the pioneer of the Ultimate Intelligent TechLuxury ultra spire market in the intelligent EV era, and a disruptor of the traditional ultra-luxury car civilization.

FF is not just an EV company, but also a software-driven company of intelligent internet AI product. Ultimately, FF aims to become a User Company by offering a shared intelligent electric mobility ecosystem.

FF envisions the growth of FF in three phases:

The phase 1 goal is to deliver the FF 91 Futurist Alliance, FF 91 Futurist and FF 91 to FF’s global ultra spire users with high quality and high product power, thereby disrupting traditional ultra-luxury brands, and ultimately becoming the leader in the global spire user market.

As the Company introduces more upcoming vehicle models, the user ecosystem will begin to take shape. FF expects that subsequent hardware revenues will grow, and the eco revenues, which include internet apps, software, and sharing, will also continue to grow. The phase 2 goal is to establish FF as a major player in the high-value user market.

During phase 3, FF intends to sustain the growth of its hardware revenues and eco revenues, which FF believes will constitute an increasingly substantial portion of the overall profit.

FF is completing its testing and validation of the FF 91 Futurist through the Product and Technology Generation 2.0 program (PT Gen 2.0). The generational upgrade from PT Gen 1.0 to PT Gen 2.0 consists of significant upgrades of systems and core components in both the vehicle and the I.A.I. area – the advanced core, which stands for Internet, Autonomous Driving, and Intelligence. PT Gen 2.0 was achieved through upgrades of 26 major systems and components, with 13 key upgrades throughout powertrain, battery, charging, chassis, interior from EV areas, and 13 key upgrades in computing, sensing, communication, user interaction, and performance of the FF 91 Futurist.

Competing with Ferrari, Maybach, Rolls Royce, and Bentley as the only next-gen Ultimate Intelligent TechLuxury EV product, the FF 91 Futurist offers a unique and intelligent EV experience with extreme technology and an ultimate user experience. The FF 91 Futurist is undergoing a series of final vehicle validation and testing before production and delivery in the coming months. Among them, the FF 91 Futurist is certified at an EPA range of 381 miles, which is the longest EPA range among electric crossovers and SUVs in the world and nearly 50-70 miles more range than similar competitors. With a 0-60 mph time of just 2.27 seconds, the FF 91 Futurist beats nearly all competitors in the ultra-luxury market segment.

Currently, we are making every effort to prepare for FF 91 Futurist production based on a detailed production plan at the FF ieFactory California. At the same time, FF will continue to promote the efficient implementation of FFIE’s US-China dual-home market and dual-DNA strategy to ensure the Company’s success in both of these two major global markets.

Users can preorder an FF 91 Futurist via the FF Intelligent App or through our website (English): https://www.ff.com/us/preorder/ or (Chinese): https://www.ff.com/cn/preorder/

Download the new FF Intelligent App (English): https://apps.apple.com/us/app/id1454187098 or https://play.google.com/store/apps/details?id=com.faradayfuture.online, (Chinese): http://appdownload.ff.com

ABOUT FARADAY FUTURE

FF is the pioneer of the Ultimate Intelligent TechLuxury ultra spire market in the intelligent EV era, and a disruptor of the traditional ultra-luxury car civilization. FF is not just an EV company, but also a software-driven company of intelligent internet AI product.

FOLLOW FARADAY FUTURE:

https://www.ff.com/

http://appdownload.ff.com

https://twitter.com/FaradayFuture

https://www.facebook.com/faradayfuture/

https://www.instagram.com/faradayfuture/

www.linkedin.com/company/faradayfuture

NO OFFER OR SOLICITATION

This communication shall neither constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

FORWARD LOOKING STATEMENTS

This press release includes “forward looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include, among other things, statements regarding the anticipated start of production (SOP) and delivery timing for our FF 91 Futurist vehicle, additional funding and timing for receipt thereof, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include whether the Amended Shareholder Agreement between the Company and FF Top, dated as of January 13, 2023, complies with the listing requirements of The Nasdaq Stock Market LLC, the market performance of the shares of the Company’s common stock; the Company’s ability to regain compliance with, and thereafter continue to comply with, the Nasdaq listing requirements; the Company’s ability to satisfy the conditions precedent and close on the various financings previously disclosed by the Company and any future financings, the failure of any of which could result in the Company seeking protection under the Bankruptcy Code; the Company’s ability to amend its certificate of incorporation to permit sufficient authorized shares to be issued in connection with the Company’s existing and contemplated financings; whether the Company and the City of Huanggang could agree on definitive documents to effectuate the non-binding Cooperation Framework Agreement; the Company’s ability to remain in compliance with its public filing requirements under the Securities Exchange Act of 1934, as amended; the outcome of the SEC investigation relating to the matters that were the subject of the Special Committee investigation and other litigation involving the Company; the Company’s ability to execute on its plans to develop and market its vehicles and the timing of these development programs; the Company’s estimates of the size of the markets for its vehicles and cost to bring those vehicles to market; the rate and degree of market acceptance of the Company’s vehicles; the success of other competing manufacturers; the performance and security of the Company’s vehicles; potential litigation involving the Company; the result of future financing efforts and general economic and market conditions impacting demand for the Company’s products; recent cost, headcount and salary reduction actions may not be sufficient or may not achieve their expected results; and the ability of the Company to attract and retain directors and employees. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s registration statement on Form S-1 filed on February 13, 2023, and other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

ADDITIONAL INFORMATION

In connection with the special stockholders meeting, the Company has filed with the SEC a definitive proxy statement on Schedule 14A with respect to the proposals therein (as amended and supplemented, the “Proxy Statement”). Faraday Future commenced mailing of the Proxy Statement to its stockholders on March 3, 2023. This press release is not a substitute for the Proxy Statement or any other document which the Company may file with the SEC. INVESTORS AND FARADAY FUTURE’S STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT IN ITS ENTIRETY AND ANY OTHER DOCUMENTS FILED BY THE COMPANY WITH THE SEC IN CONNECTION WITH THE PROXY STATEMENT OR INCORPORATED BY REFERENCE THEREIN BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSALS IN THE PROXY STATEMENT. Investors and stockholders may obtain free copies of the Proxy Statement and other documents containing important information about Faraday Future that are filed or will be filed with the SEC by Faraday Future from the SEC’s website at www.sec.gov. Faraday Future makes available free of charge at www.ff.com (in the “Financials and Filings” section), copies of materials it files with, or furnish to, the SEC.

PARTICIPANTS IN SOLICITATION

Faraday Future and its respective directors and executive officers and certain Company investors and their representatives may be deemed participants in the solicitation of proxies of the Company’s stockholders in respect of the proposals in the Proxy Statement. Information about the directors and executive officers of Faraday Future, such investors and their representatives and their ownership is set forth in the Company’s filings with the SEC, including the Proxy Statement. These documents can be obtained free of charge from the sources specified above.

Investors (English):[email protected]

Investors (Chinese):[email protected]

Media:[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Vehicle Technology Automotive Automotive Manufacturing General Automotive EV/Electric Vehicles Manufacturing Alternative Vehicles/Fuels

MEDIA:

Logo
Logo

NOVAGOLD Releases Its 2022 Annual Report Featuring a Conversation Between Dr. Thomas S. Kaplan and Daniela Cambone

  • NOVAGOLD’s Chairman Dr. Thomas S. Kaplan and Daniela Cambone, Editor-at-Large and Host of The Daniela Cambone Show at Stansberry Research, had a wide-ranging discussion spanning geopolitics, history, markets, investment strategy, gold opportunities, and NOVAGOLD’s 2022 achievements.
  • Our President and CEO, Greg Lang, summarizes the many advancements of NOVAGOLD’s 50%-owned Donlin Gold project in 2022, including its outstanding safety performance with zero lost-time incidents at site and the 141-hole, 42,331-meter drill program that returned numerous high-grade gold intercepts and good grade continuity, which exceeded expectations.

VANCOUVER, British Columbia, March 09, 2023 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) has published its 2022 Annual Report (the “annual report”). This year’s annual report features a special conversation between NOVAGOLD’s Chairman Dr. Thomas S. Kaplan and Daniela Cambone, Editor-at-Large and Host of The Daniela Cambone Show at Stansberry Research. Their discussion covers a broad range of topics including geopolitics, history, markets, opportunities for gold and gold equities and their macro impact, central banks as the largest buyers of gold — both presently and historically — and the corresponding potential upside for the premier “go-to” development stories in safe jurisdictions like NOVAGOLD, along with the 2022 achievements that reinforced its Tier 1 profile. The interview was recorded at the New York Stock Exchange on November 29, 2022, with a full transcript available in the annual report and via this video link.

In the annual report, President and CEO Greg Lang summarizes NOVAGOLD’s numerous achievements from 2022, including the Company’s outstanding safety performance and the remarkable results from Donlin Gold’s largest drill program in 15 years, which returned not only good grade continuity but among the highest-grade gold intercepts in the gold mining industry. Mr. Lang highlights the strong, time-tested relationships with Donlin Gold’s Alaska Native Corporation partners — Calista Corporation and The Kuskokwim Corporation — with whom the Company is committed to responsible and sustainable development in the Yukon-Kuskokwim region. In addition, Mr. Lang provides an overview of NOVAGOLD’s robust financial position and the path forward in 2023.

The 2022 annual report is available on NOVAGOLD’s website here.

If you would like to receive a hard copy by mail, please send an email request to [email protected].

NOVAGOLD welcomes comments, questions, or suggestions about the annual report and related information. Please send your feedback to [email protected].

NOVAGOLD Contacts:

Mélanie Hennessey
Vice President, Corporate Communications

604-669-6227 or 1-866-669-6227

Cautionary Note Regarding Forward-Looking Statements

This media release includes certain “forward-looking information” and “forward-looking statements” (collectively “forward-looking statements”) within the meaning of applicable securities legislation, including the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are frequently, but not always, identified by words such as “expects”, “anticipates”, “believes”, “intends”, “estimates”, “potential”, “possible”, and similar expressions, or statements that events, conditions, or results “will”, “may”, “could”, “would” or “should” occur or be achieved. Forward-looking statements are necessarily based on several opinions, estimates and assumptions that management of NOVAGOLD considered appropriate and reasonable as of the date such statements are made, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, activity, performance, or achievements to be materially different from those expressed or implied by such forward-looking statements. All statements, other than statements of historical fact, included herein are forward-looking statements. These forward-looking statements include statements regarding the anticipated timing of certain judicial and/or administrative decisions; the 2023 outlook; the timing and potential for an updated feasibility study on the project; our goals and planned expenditures for the remainder of 2023; ongoing support provided to key stakeholders including Native Corporation partners; Donlin Gold’s continued support for the State permitting process; the potential development and construction of Donlin Gold; the sufficiency of funds to continue to advance development of Donlin Gold, including to a construction decision; perceived merit of properties; mineral reserve and mineral resource estimates; Donlin Gold’s ability to secure the permits needed to construct and operate the Donlin Gold project in a timely manner, if at all; legal challenges to Donlin Gold’s existing permits and the timing of decisions in those challenges; whether the Donlin Gold LLC Board will continue to advance Donlin Gold up the value chain; the success of the strategic mine plan for Donlin Gold; the outcome of exploration drilling at Donlin Gold and the timing thereof; and the conversion of Galore Creek into a mine and the receipt of $25 million due in July 2023 from Newmont Corporation and the $75 million contingent payment from Newmont. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements are not historical facts but instead represent the expectations of NOVAGOLD management’s estimates and projections regarding future events or circumstances
on the date the statements are made.

Important factors that could cause actual results to differ materially from expectations include the need to obtain additional permits and governmental approvals; the timing and likelihood of obtaining and maintaining permits necessary to construct and operate; the need for additional financing to explore and develop properties and availability of financing in the debt and capital markets; the coronavirus global pandemic (COVID-19); uncertainties involved in the interpretation of drill results and geological tests and the estimation of reserves and resources; changes in mineral production performance, exploitation and exploration successes; changes in national and local government legislation, taxation, controls or regulations and/or changes in the administration of laws, policies and practices, expropriation or nationalization of property and political or economic developments in the United States or Canada; the need for continued cooperation between Barrick and NOVAGOLD for the continued exploration, development and eventual construction of the Donlin Gold property; the need for cooperation of government agencies and Native groups in the development and operation of properties; risks of construction and mining projects such as accidents, equipment breakdowns, bad weather, disease pandemics, non-compliance with environmental and permit requirements, unanticipated variation in geological structures, ore grades or recovery rates; unexpected cost increases, which could include significant increases in estimated capital and operating costs; fluctuations in metal prices and currency exchange rates; whether or when a positive construction decision will be made regarding Donlin Gold; and other risks and uncertainties disclosed in NOVAGOLD’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports and other documents filed by NOVAGOLD with applicable securities regulatory authorities from time to time. Copies of these filings may be obtained by visiting NOVAGOLD’s website at
www.novagold.com
, or the SEC’s website at
www.sec.gov, or at www.sedar.com. The forward-looking statements contained herein reflect the beliefs, opinions and projections of NOVAGOLD on the date the statements are made. NOVAGOLD assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

 



Jeffrey Dunne Elected to the Board of Directors of Bankwell Financial Group, Inc. and Bankwell Bank

Jeffrey Dunne Elected to the Board of Directors of Bankwell Financial Group, Inc. and Bankwell Bank

NEW CANAAN, Conn.–(BUSINESS WIRE)–
Effective March 9, 2023, the Boards of Directors of Bankwell Financial Group, Inc. (the “Company”) and its wholly-owned subsidiary, Bankwell Bank (together with the Company, “Bankwell”) elected Jeffrey Dunne to serve as a Director of the Company and Bankwell Bank.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230309005825/en/

Jeffrey Dunne, Director (Photo: Business Wire)

Jeffrey Dunne, Director (Photo: Business Wire)

Bringing more than 30 years’ experience, Mr. Dunne is a Vice Chairman at CBRE, Inc. and oversees the New York Capital Markets team that sells income producing multi-family, office, retail and industrial assets. The team’s business is largely transacted in the New York Region, though the group also sells portfolios throughout the United States. Mr. Dunne is active in various charity and community organizations and sits on the Board of Trustees of the Wakeman Boys & Girls Club, the Real Estate Advisory Board at Pennsylvania State University’s Smeal School of Business and Bishop Caggiano’s Real Estate Board. In 2012, Mr. Dunne was honored by the March of Dimes, receiving its annual Real Estate Award and, in 2013, he received the Edward S. Gordon Award. He is a graduate of Pennsylvania State University and holds an M.B.A. from New York University.

Bankwell’s Chairman Blake Drexler states, “We are excited to welcome Jeff to Bankwell’s Board of Directors. Jeff’s vast experience in real estate, financial acumen, leadership skills and his community involvement make him an ideal addition to our board.”

Bankwell is a commercial bank that provides banking and lending services to businesses and residents. Bankwell was founded on the principles of providing an exceptional banking experience and adding value to the communities it serves. For more information about this press release, interested parties may contact Laura Waitz, Executive Vice President and Chief Operating Officer of Bankwell Financial Group at (203) 652-0166. More about Bankwell can be found at www.mybankwell.com.

Bankwell Financial Group

Laura Waitz, Executive Vice President and Chief Operating Officer

203-652-0166

KEYWORDS: Connecticut United States North America

INDUSTRY KEYWORDS: Banking Professional Services

MEDIA:

Photo
Photo
Jeffrey Dunne, Director (Photo: Business Wire)
Logo
Logo

Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

— CB-010 ANTLER Phase 1 trial in r/r B-NHL ongoing with update planned for H2 2023 —

— CB-011 CaMMouflage Phase 1 trial in r/r MM recruiting patients at dose level 1 —

— CB-012 IND-enabling studies initiated; IND submission in r/r AML planned for H2 2023 —

— $317.0 million in cash, cash equivalents, and marketable securities as of December 31, 2022; cash runway to fund the current operating plan into 2025 —

BERKELEY, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial results for the fourth quarter and full year 2022 and reviewed recent pipeline progress.

“We successfully demonstrated the potential of our chRDNA genome-editing technology with promising clinical data from CB-010, our lead allogeneic cell therapy,” said Rachel Haurwitz, PhD, Caribou’s president and chief executive officer. “The initial dose level of CB-010 demonstrated 6-month complete response rates that have the potential to rival the responses seen with approved autologous CAR-T cell therapies. We are excited that the FDA granted the CB-010 program RMAT and Fast Track designations last year. Our team drove additional pipeline progress with an IND clearance for CB-011, enabling us to activate clinical sites for our CaMMouflage Phase 1 trial. In 2023, Caribou plans to maintain this momentum by advancing two ongoing clinical trials for our off-the-shelf cell therapies in patients with hematologic malignancies and preparing an IND submission for our third program, CB-012.”

Accomplishments and Highlights

Pipeline and Technology

  • CB-010: Caribou reported promising data at dose level 1 (40×106 CAR-T cells) from its ongoing ANTLER Phase 1 clinical trial of CB-010 in patients with relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL).

    • Following a single infusion of CB-010 at dose level 1, all 6 patients in cohort 1 achieved complete responses as their best response. 3 of 6 patients maintained complete responses at 6 months, with 2 of 6 maintaining complete responses at 12 months. Caribou plans to provide an update from the ongoing ANTLER Phase 1 trial for CB-010 in H2 2023.
    • Clinical data presentations are available on Caribou’s website under Scientific Publications.
    • Following demonstration of an encouraging safety profile at dose level 2 (80×106 CAR-T cells), with no dose-limiting toxicities (DLTs) in the 3 patients treated, Caribou continues to enroll patients at dose level 3 (120×106 CAR-T cells).
    • The U.S. Food and Drug Administration (FDA) has granted CB-010 Regenerative Medicine Advanced Therapy (RMAT), Fast Track, and Orphan Drug designations. These designations provide important benefits in the drug development process and are designed to facilitate and expedite development and regulatory review, including providing eligibility for priority and rolling reviews and accelerated approval, if relevant criteria are satisfied.
    • CB-010 is the first allogeneic anti-CD19 CAR-T cell therapy in the clinic, to Caribou’s knowledge, with a PD-1 knockout (KO), a genome-editing strategy designed to improve antitumor activity by limiting premature CAR-T cell exhaustion.
    • Additional information on the ANTLER trial (NCT04637763) can be found at clinicaltrials.gov.
  • CB-011: Caribou recently activated clinical sites for the recruitment of patients at dose level 1 (50×106 CAR-T cells) of CB-011 in the CaMMouflage Phase 1 trial for relapsed or refractory multiple myeloma (r/r MM).

    • CB-011 is the first allogeneic CAR-T cell therapy in the clinic, to Caribou’s knowledge, that is engineered to improve antitumor activity through an immune cloaking strategy with a B2M KO and insertion of a B2M–HLA-E fusion protein to blunt immune-mediated rejection.
    • Preclinical data for CB-011 were presented in a poster at the 2023 Tandem Meeting: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, February 15-19, 2023, in Orlando, Florida. The poster presentation is available on Caribou’s website under Scientific Publications.
    • Additional information on the CaMMouflage trial (NCT05722418) can be found at clinicaltrials.gov.
  • CB-012: Caribou has initiated IND-enabling studies for CB-012, an allogeneic anti-CLL-1 CAR-T cell therapy, to support a planned IND application submission for relapsed or refractory acute myeloid leukemia (r/r AML).

    • CB-012 is the first allogeneic CAR-T cell therapy, to Caribou’s knowledge, with both checkpoint disruption, through a PD-1 KO, and immune cloaking, through a B2M KO and B2M–HLA-E fusion protein insertion; both armoring strategies are designed to improve antitumor activity. CB-012 is engineered with 5 genome edits, enabled by Caribou’s next-generation CRISPR technology platform, which uses Cas12a chRDNA genome editing to significantly improve the specificity of genome edits.
    • In preclinical AML models, CB-012 significantly reduced tumor burden and increased overall survival compared to controls.
  • CB-020: Caribou’s first induced pluripotent stem cell (iPSC)-derived allogeneic CAR-NK cell therapy, CB-020, is designed to target solid tumors expressing the tumor antigen ROR1.

    • Preclinical data supporting the selection of the ROR1 CAR construct and armoring strategies for the company’s CAR-NK cell platform were presented at the 12th American Association for Cancer Research and Japanese Cancer Association (AACR-JCA) Joint Conference in December 2022. The poster presentation is available on Caribou’s website under Scientific Publications.

Anticipated 2023 Milestones

  • CB-010: Caribou plans to provide an update from the ongoing ANTLER Phase 1 trial for CB-010 in H2 2023.
  • CB-011: Caribou recently activated clinical sites for the recruitment of patients at dose level 1 and plans to provide an update on the clearance of dose levels as appropriate from the CaMMouflage Phase 1 trial for CB-011.
  • CB-012: Caribou plans to submit an IND application for CB-012 in H2 2023.

Upcoming Investor Conferences

  • Caribou management plans to participate in the following investor conferences:
    • March 15: Oppenheimer’s 33rd Annual Healthcare Investor Conference, virtual
    • May 9-11: BofA Securities 2023 Healthcare Conference, Las Vegas

Fourth Quarter and Full Year 2022 Financial Results

Cash, cash
equivalents, and marketable securities: Caribou had $317.0 million in cash, cash equivalents, and marketable securities as of December 31, 2022, compared to $413.5 million as of December 31, 2021. Caribou expects these cash, cash equivalents, and marketable securities will be sufficient to fund its current operating plan into 2025.

Licensing and collaboration revenue: Revenue from Caribou’s licensing and collaboration agreements was $3.7 million for the three months ended December 31, 2022 and $13.9 million for the full year 2022, compared to $2.6 and $9.6 million, respectively, for the same periods in 2021. The increases were primarily due to revenue recognized under the AbbVie Agreement.

R&D expenses: Research and development expenses were $25.7 million for the three months ended December 31, 2022 and $82.2 million for the full year 2022, compared to $15.1 and $52.3 million, respectively, for the same periods in 2021. The increases were primarily due to costs to advance pipeline programs; increased headcount, including stock-based compensation; facilities and other allocated expenses; and increased external manufacturing and clinical activities.

G&A expenses: General and administrative expenses were $8.5 million for the three months ended December 31, 2022 and $38.0 million for the full year 2022, compared to $7.9 and $24.3 million, respectively, for the same periods in 2021. The increases were primarily due to increased headcount, including stock-based compensation; legal, accounting, insurance, and other expenses necessary to support the growth and operation of a clinical-stage public company; and facilities and other allocated expenses.

Net loss: Caribou reported a net loss of $27.0 million for the three months ended December 31, 2022 and $99.4 million for the full year 2022, compared to $18.5 and $66.9 million, respectively, for the same periods in 2021.

About Caribou’s Novel Next-Generation CRISPR Platform

CRISPR genome editing uses easily designed, modular biological tools to make DNA changes in living cells. There are two basic components of Class 2 CRISPR systems: the nuclease protein that cuts DNA and the RNA molecule(s) that guide the nuclease to generate a site-specific, double-stranded break, leading to an edit at the targeted genomic site. CRISPR systems are capable of editing unintended genomic sites, known as off-target editing, which may lead to harmful effects on cellular function and phenotype. In response to this challenge, Caribou has developed CRISPR hybrid RNA-DNA guides (chRDNAs; pronounced “chardonnays”) that direct substantially more precise genome editing compared to all-RNA guides. Caribou is deploying the power of its Cas12a chRDNA technology to carry out high efficiency multiple edits, including multiplex gene insertions, to develop CRISPR-edited therapies.

About Caribou Biosciences, Inc.

Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its proprietary Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve antitumor activity. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T and CAR-NK platforms as readily available treatments for patients with hematologic malignancies and solid tumors.

Follow us @CaribouBio and visit www.cariboubio.com.

“Caribou Biosciences” and the Caribou logo are registered trademarks of Caribou Biosciences, Inc.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements related to Caribou’s strategy, plans, and objectives, and expectations regarding its clinical and preclinical development programs, including its expectations relating to the timing of updates from its ANTLER Phase 1 clinical trial for CB-010 as well as the status and updates from its CaMMouflage Phase 1 clinical trial for CB-011, expectations about product developments in 2023, and the submission of an IND application for CB-012. Management believes that these forward-looking statements are reasonable as and when made. However, such forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, risks inherent in the development of cell therapy products; uncertainties related to the initiation, cost, timing, progress, and results of Caribou’s current and future research and development programs, preclinical studies, and clinical trials; and the risk that initial or interim clinical trial data will not ultimately be predictive of the safety and efficacy of Caribou’s product candidates or that clinical outcomes may differ as more patient data becomes available; the risk that preclinical study results we observed will not be borne out in human patients; as well as other risk factors described from time to time in Caribou’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent filings. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, Caribou undertakes no obligation to update publicly any forward-looking statements for any reason.

Caribou Biosciences, Inc.
Condensed Consolidated Balance Sheet Data
(in thousands)
(unaudited)   

  December 31,

2022
  December 31,

2021
Cash, cash equivalents, and marketable securities $ 317,036     $ 413,508  
Total assets   373,765       442,356  
Total liabilities   72,894       54,531  
Total stockholders’ equity   300,871       387,825  
Total liabilities and stockholders’ equity $ 373,765     $ 442,356  

 

 

Caribou Biosciences, Inc.
Condensed Consolidated Statement of Operations
(in thousands, except share and per share data)
(unaudited)

  Three Months Ended

December 31,
  Year Ended

December 31,
    2022       2021       2022       2021  
Licensing and collaboration revenue $ 3,692     $ 2,559     $ 13,851     $ 9,598  
Operating expenses:              
Research and development   25,736       15,111       82,230       52,255  
General and administrative   8,534       7,853       38,020       24,322  
Total operating expenses   34,270       22,964       120,250       76,577  
Loss from operations   (30,578 )     (20,405 )     (106,399 )     (66,979 )
Other income (expense):              
Change in fair value of equity securities   (60 )           (133 )      
Change in fair value of the MSKCC success payments liability   1,388       2,158       2,429       (1,426 )
Gain on extinguishment of PPP Loan                     1,584  
Other income, net   2,331       89       4,752       219  
Total other income (expense)   3,659       2,247       7,048       377  
Net loss before provision for income taxes $ (26,919 )   $ (18,158 )   $ (99,351 )   $ (66,602 )
Provision for income taxes   70       321       70       321  
Net loss $ (26,989 )   $ (18,479 )   $ (99,421 )   $ (66,923 )
Other comprehensive loss:              
Net unrealized loss on available-for-sale marketable securities   517       (135 )     (1,383 )     (135 )
Net comprehensive loss $ (26,472 )   $ (18,614 )   $ (100,804 )   $ (67,058 )
Net loss per share, basic and diluted $ (0.44 )   $ (0.31 )   $ (1.64 )   $ (2.11 )
Weighted-average common shares outstanding, basic and diluted   61,001,150       60,180,759       60,801,133       31,663,243  

 

Caribou Biosciences Contacts:

Investors:

Amy Figueroa, CFA
[email protected]

Media:

Peggy Vorwald, PhD
[email protected]



Qualtrics Announces 2023 XM Breakthrough Artist Awards, Recognizing Brands Creating Revolutionary Experiences

Qualtrics Announces 2023 XM Breakthrough Artist Awards, Recognizing Brands Creating Revolutionary Experiences

Experience leaders from world’s top brands – including Disney, Chipotle, and Delta – are using feedback, data, and analytics to build deeper relationships with their employees and customers and create breakthrough experiences in order to thrive in challenging times.

SALT LAKE CITY–(BUSINESS WIRE)–QUALTRICS X4 — Qualtrics (Nasdaq: XM), the leader and creator of the experience management category, today announced the winners of the 2023 XM Breakthrough Artists awards, recognizing leaders and innovators who are creating breakthrough experiences.

This year’s winners used Qualtrics to help them revolutionize car buying, improve restaurant experiences, and design a set of crayons that more accurately reflects the diversity of the world.

Disney, Chipotle, Delta, Rivian, Uber and Crayola were recognized on stage at X4™: The Experience Management Summit for their pioneering and inventive approaches to creating extraordinary employee and customer experiences, including investments in improving diversity, equity and inclusion, a category added in 2022. Each winner received a custom Yamaha Revstar guitar conceptualized by Qualtrics and laser-engraved by Big Secret in Richmond, VA. Its design proudly signifies the boldness and attention to detail our Breakthrough Artists exemplified.

“The world’s top brands aren’t known for what they sell, but how they make customers feel,” said Qualtrics Chief Category & Brand Officer Kylan Lundeen. “This year’s XM Breakthrough Artist awards recognize the brands that are driving business results through authentic & meaningful experiences by listening to customers & employees, identifying needs, and executing in spectacular fashion.”

Delta – Experience Management Breakthrough Artist Winner

Delta Air Lines, recently named the Top U.S. Airline of 2022 by the Wall Street Journal in its annual airline scorecard and one of Fast Company’s 2023 Most Innovative Companies worldwide, is dedicated to continuing to elevate the travel journey. The company is focused on delivering personalized journeys across both digital and in-person channels using in-moment feedback to further enhance the customer and employee experience. In January 2023, Delta announced free Wi-Fi for Delta SkyMiles members on most domestic mainline flights – listening, understanding and pivoting as needed based on how customers respond. Delta has long realized that providing humanity into the travel experience improves customer and employee outcomes; the data now being captured with Qualtrics will aid in reinforcing that.

Chipotle – Employee Experience Breakthrough Artist Winner

As the largest national fast-casual restaurant brand, Chipotle employs more than 100,000 people. Their “Chipeeps” – or Chipotle people – are at the heart of everything they do. Chipotle partnered with Qualtrics to gain insights on how each restaurant team’s experience affected customer perception.

From food taste to order accuracy and service speed, the Chipotle team discovered that customers are consistently more satisfied at restaurant locations where employees reported high levels of trust and respect for one another, good communication from the executive team, and involvement in decisions that affect their work. The project inspired additional efforts to better understand EX and CX connections to ultimately bolster both its employee and guest experiences.

Disney – Customer Experience Breakthrough Artist Winner

Disney+ worked with Qualtrics to paint a complete picture of their audiences’ needs before launching the direct-to-consumer streaming platform in 2019. The company leveraged Qualtrics DesignXM and CX alongside additional services from Qualtrics, including Advanced Survey features for collection of score and qualitative feedback, XiD for audience management, Stats iQ for analysis, and even Text iQ for text analysis. It worked – in less than four years, Disney+ has grown its reach to nearly 162 million subscribers globally.

Rivian – Product Experience Breakthrough Artist Winner

In order to enable extraordinary adventures, Rivian is revolutionizing the experience of buying a new vehicle. Rivian is moving away from a disparate, siloed purchase process – which customers had to navigate alone – to one that is seamlessly connected, simple to navigate, and where information easily flows between each stage of the digital experience.

Whether it’s reinventing the vehicle purchase process or upending how vehicle financing is acquired, Rivian is committed to providing customers an exceptional experience in their path to ownership. That’s why they are this year’s PX Breakthrough Artist Winner.

Uber – Brand Experience Breakthrough Artist Winner

The Uber team has been working with Qualtrics on their brand tracker for more than three years. They use Qualtrics to understand and track the health of the Uber and Uber Eats brands across global key markets. This program provides strategic insights to inform the roadmap for new research and product development, as well as marketing initiatives throughout the year.

With this program, Uber has been able to identify pain points and understand key drivers of brand favorability, consideration, preference and trust and take action. The team also uses the tracker as a starting point for new research and identifies gaps in their knowledge.

Crayola – DEI Breakthrough Artist Winner

A brand that’s still innovating after 120 years, Crayola believes kids should have the power to create their place in the world by coloring themselves into it. The company introduced Multicultural Crayons more than 30 years ago. Beginning in 2019, they partnered with Qualtrics through 4 rounds of feedback from more than 9000 consumers as well as industry experts both in product development and their own internal processes inside the company to ensure they were authentic, credible and transparent in the creation of Colors of the World.

In 2020, Crayola announced the new Colors of the World crayons, a line of 24 specially formulated crayons representing more than 40 global skin tones designed to meet the needs of today’s increasingly diverse world and promote the importance of inclusion and self-expression. For the role they play in empowering everyone with the ability to self-express, Crayola is this year’s DEI Breakthrough Artist Winner.

About Qualtrics

Qualtrics, the leader and creator of the experience management category, is a cloud-native software provider that helps organizations quickly identify and resolve points of friction across all digital and human touchpoints in their business – so they can retain their best customers and employees, protect their revenue, and drive profitability. More than 18,750 organizations around the world use Qualtrics’s advanced AI to listen, understand, and take action. Qualtrics uses its vast universe of experience data to form the largest database of human sentiment in the world. Qualtrics is co-headquartered in Provo, Utah and Seattle, and operates out of 28 offices globally. To learn more, please visit qualtrics.com.

Max Frost, Qualtrics

[email protected]

KEYWORDS: United States North America Utah

INDUSTRY KEYWORDS: Technology Human Resources Public Relations/Investor Relations Communications Professional Services Software Internet DEI (Diversity, Equity and Inclusion) Data Management Artificial Intelligence

MEDIA:

Logo
Logo

DNP Select Income Fund Inc. Section 19(a) Notice

DNP Select Income Fund Inc. Section 19(a) Notice

CHICAGO–(BUSINESS WIRE)–
DNP Select Income Fund Inc. (NYSE: DNP):

Notification of Sources of Distribution

 

Distribution Period

February 2023

Distribution Amount Per Share of Common Stock

$0.065

The following table sets forth the estimated amounts of the current distribution, payable March 10, 2023 to shareholders of record February 28, 2023, together with the cumulative distributions paid this fiscal year-to-date (YTD) from the following sources. The fiscal year is November 1, 2022 to October 31, 2023. All amounts are expressed per share of common stock based on U.S. generally accepted accounting principles, which may differ from federal income tax regulations.

Distribution Estimates

February 2023

Fiscal YTD

Sources

Per Share Amount

% of Current

Distribution

Per Share Amount

% of Cumulative

Distributions

Net Investment Income

$

0.005

8%

$

0.057

22%

Net Realized Short-Term Capital Gains

 

0.001

1%

 

0.003

1%

Net Realized Long-Term Capital Gains

 

0.015

23%

 

0.156

60%

Return of Capital (or Other Capital Source)

 

0.044

68%

 

0.044

17%

Total (per common share)

$

0.065

100%

$

0.260

100%

 

January 31, 2023

 

Average annual total return* on NAV for the 5 years

 

 

8.86%

Annualized current distribution rate as a percentage of NAV

 

 

8.52%

Cumulative total return on NAV for the fiscal YTD

 

 

8.14%

Cumulative fiscal YTD distributions as a percentage of NAV

 

 

2.13%

The Fund will issue a separate 19(a) notice at the time of each monthly distribution using the most current financial information available. You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution plan.

The Fund estimates that it has distributed more than its income and capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund’s investment performance and should not be confused with “yield” or “income.”

The amounts and sources of distributions reported in this notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of the fiscal year and may be subject to changes based on tax regulations. The Fund or your broker will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

* Simple arithmetic average of each of the past five annual returns.

DNP Select Income Fund Inc. (NYSE: DNP) is a closed-end diversified investment management company. The Fund’s primary investment objectives are current income and long-term growth of income. The Fund seeks to achieve these objectives by investing primarily in a diversified portfolio of equity and fixed income securities of companies in the public utilities industry. For more information, visit the Fund’s website at www.dpimc.com/dnp or call the Fund at (800) 864-0629.

Dianna P. Wengler or Donny C. Overton

Phone: (833) 604-3163

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA: